{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:50:24Z","timestamp":1790704224826,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jaci.2018.01.031","type":"journal-article","created":{"date-parts":[[2018,2,10]],"date-time":"2018-02-10T02:24:49Z","timestamp":1518229489000},"page":"1726-1734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Chronic inducible urticaria: A\u00a0systematic review of treatment options"],"prefix":"10.1016","volume":"141","author":[{"given":"Corinna","family":"Dressler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Niklas","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Eisert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1466-8875","authenticated-orcid":false,"given":"Torsten","family":"Zuberbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Nast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4121-481X","authenticated-orcid":false,"given":"Marcus","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2018.01.031_bib1","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/all.12884","article-title":"The definition, diagnostic testing, and management of chronic inducible urticarias\u2014the EAACI\/GA(2) LEN\/EDF\/UNEV consensus recommendations 2016 update and revision","volume":"71","author":"Magerl","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.01.031_bib2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/00325481.2015.1045817","article-title":"Physical urticaria: review on classification, triggers and management with special focus on prevalence including a meta-analysis","volume":"127","author":"Trevisonno","year":"2015","journal-title":"Postgrad Med"},{"key":"10.1016\/j.jaci.2018.01.031_bib3","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jaip.2016.09.029","article-title":"Prevalence of inducible urticaria in patients with chronic spontaneous urticaria: associated risk factors","volume":"5","author":"Sanchez","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2018.01.031_bib4","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/all.12313","article-title":"The EAACI\/GA(2)LEN\/EDF\/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update","volume":"69","author":"Zuberbier","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.01.031_bib5","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2011"},{"key":"10.1016\/j.jaci.2018.01.031_bib6","unstructured":"PRISMA: transparent reporting of systematic reviews and meta-analyses. Available at: http:\/\/www.prisma-statement.org\/index.htm. Accessed June 10, 2017."},{"key":"10.1016\/j.jaci.2018.01.031_bib7","unstructured":"Scottish Intercollegiate Guidelines Network. Search filters 2015 (updated 27.08.2015). Available at: http:\/\/www.sign.ac.uk\/methodology\/filters.html. Accessed November 24, 2015."},{"key":"10.1016\/j.jaci.2018.01.031_bib8","unstructured":"Review Manager (RevMan). Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014."},{"key":"10.1016\/j.jaci.2018.01.031_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin trials"},{"key":"10.1016\/j.jaci.2018.01.031_bib10","first-page":"56","article-title":"Rupatadine 20 mg and 40 mg are effective in reducing the symptoms of chronic cold urticaria","volume":"96","author":"Abajian","year":"2016","journal-title":"Acta Dermatovenereol"},{"key":"10.1016\/j.jaci.2018.01.031_bib11","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1067\/mjd.2003.144","article-title":"Mizolastine in primary acquired cold urticaria","volume":"48","author":"Dubertret","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2018.01.031_bib12","first-page":"516","article-title":"Critical temperature threshold reduction in acquired cold urticaria Patients treated with rupatadine: a randomised, doubleblind, cross-over, placebo-controlled study","volume":"64","author":"Gimenez-Arnau","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.01.031_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11882-010-0113-3","article-title":"Treatment of cold urticaria","volume":"10","author":"Kaplan","year":"2010","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2018.01.031_bib14","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/all.12171","article-title":"Up-dosing with bilastine results in improved effectiveness in cold contact urticaria","volume":"68","author":"Krause","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.01.031_bib15","first-page":"823","article-title":"Effect of mizolastine vs placebo in acquired cold induced urticaria (ACIU): the cold stimulation time test","volume":"108","author":"Levnadier","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.01.031_bib16","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1365-2133.2012.10822.x","article-title":"Critical temperature threshold measurement for cold urticaria: a randomized controlled trial of H(1)-antihistamine dose escalation","volume":"166","author":"Magerl","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2018.01.031_bib17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.anai.2009.11.013","article-title":"Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria","volume":"104","author":"Metz","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2018.01.031_bib18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000248523","article-title":"Comparison of the new antihistamine acrivastine (BW 825C) versus cyproheptadine in the treatment of idiopathic cold urticaria","volume":"177","author":"Neittaanmaki","year":"1988","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaci.2018.01.031_bib19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0190-9622(84)70196-4","article-title":"Comparison of cinnarizine, cyproheptadine, doxepin, and hydroxyzine in treatment of idiopathic cold urticaria: usefulness of doxepin","volume":"11","author":"Neittaanmaki","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2018.01.031_bib20","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jaci.2008.12.008","article-title":"High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study","volume":"123","author":"Siebenhaar","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.01.031_bib21","first-page":"840","article-title":"Effect of ketotifen treatment on cold-induced urticaria","volume":"55","author":"St-Pierre","year":"1985","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaci.2018.01.031_bib22","first-page":"258","article-title":"A comparison of new nonsedating and classical antihistamines in the treatment of primary acquired cold urticaria (ACU)","volume":"2","author":"Villas Martinez","year":"1992","journal-title":"J Invest Allergol Clin Immunol"},{"key":"10.1016\/j.jaci.2018.01.031_bib23","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/archderm.1977.01640100053005","article-title":"Primary acquired cold urticaria. Double-blind comparative study of treatment with cyproheptadine, chlorpheniramine, and placebo","volume":"113","author":"Wanderer","year":"1977","journal-title":"Arch Dermatol"},{"issue":"suppl\u00a02","key":"10.1016\/j.jaci.2018.01.031_bib24","first-page":"9B","article-title":"Acrivastine versus terfenadine in the treatment of symptomatic dermographism\u2014a double-blind, placebo-controlled study","volume":"17","author":"Boyle","year":"1989","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jaci.2018.01.031_bib25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2133.1985.tb02319.x","article-title":"A comparison of astemizole and chlorpheniramine in dermographic urticaria","volume":"112","author":"Krause","year":"1985","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2018.01.031_bib26","first-page":"88","article-title":"Efficacy of H, antihistamine, corticosteroids and cyclophosphamide in the treatment of chronic dermographic urticaria","volume":"68","author":"Kumar","year":"2002","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaci.2018.01.031_bib27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000248580","article-title":"Calcium antagonist in the treatment of symptomatic dermographism. Low-dose and high-dose studies with nifedipine","volume":"177","author":"Lawlor","year":"1988","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaci.2018.01.031_bib28","first-page":"185","article-title":"Omalizumab is effective and safe in symptomatic dermographism: results of UFO, a multicentre randomized, placebo-controlled trial","volume":"71","author":"Metz","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.01.031_bib29","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-2133.1993.tb00488.x","article-title":"The effect of cetirizine on symptoms and wealing in dermographic urticaria","volume":"129","author":"Sharpe","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2018.01.031_bib30","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/0190-9622(91)70163-V","article-title":"Therapeutic effects of cetirizine in delayed pressure urticaria: clinicopathologic findings","volume":"24","author":"Kontou-Fili","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2018.01.031_bib31","first-page":"517","article-title":"Therapeutic effects of cetirizine in delayed pressure urticaria. Part 1. Effects on weight tests and skin-window cytology","volume":"65","author":"Kontou-Fili","year":"1990","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaci.2018.01.031_bib32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2133.1989.tb04167.x","article-title":"Delayed pressure urticaria, objective evaluation of a variable disease using a dermographometer and assessment of treatment using colchicine","volume":"120","author":"Lawlor","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2018.01.031_bib33","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1365-2133.2006.07533.x","article-title":"Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: a randomized, double-blind, placebo-controlled study","volume":"155","author":"Nettis","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2018.01.031_bib34","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1067\/mai.2003.1559","article-title":"Efficacy of montelukast, in combination with loratadine, in the treatment of delayed pressure urticaria","volume":"112","author":"Nettis","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.01.031_bib35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/WOX.0b013e31825a72fc","article-title":"Evaluation of different combined regimens in the treatment of cholinergic urticaria","volume":"5","author":"Alsamarai","year":"2012","journal-title":"World Allergy Org J"},{"key":"10.1016\/j.jaci.2018.01.031_bib36","first-page":"541","article-title":"Acrivastine versus hydroxyzine in the treatment of cholinergic urticaria. A\u00a0placebo-controlled study","volume":"68","author":"Kobza Black","year":"1988","journal-title":"Acta Dermatovenereol"},{"key":"10.1016\/j.jaci.2018.01.031_bib37","first-page":"147","article-title":"Efficacy of cetirizine in cholinergic urticaria","volume":"75","author":"Zuberbier","year":"1995","journal-title":"Acta Dermatovenereol"},{"key":"10.1016\/j.jaci.2018.01.031_bib38","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000246281","article-title":"Double-blind crossover study of high-dose cetirizine in cholinergic urticaria","volume":"193","author":"Zuberbier","year":"1996","journal-title":"Dermatology"},{"key":"10.1016\/j.jaci.2018.01.031_bib39","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jaci.2017.01.043","article-title":"Omalizumab is effective in cold urticaria\u2014results of a randomized placebo-controlled trial","volume":"140","author":"Metz","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.01.031_bib40","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaci.2017.01.042","article-title":"Omalizumab is effective in symptomatic dermographism-results of a randomized placebo-controlled trial","volume":"140","author":"Maurer","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.01.031_bib41","first-page":"509","article-title":"[Effect of ketotifen in urticaria factitia and urticaria cholinergica in a crossover double-blind trial]","volume":"36","author":"Cap","year":"1985","journal-title":"Hautarzt"},{"key":"10.1016\/j.jaci.2018.01.031_bib42","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jaci.2017.06.032","article-title":"Omalizumab treatment in patients with chronic inducible urticaria: a systematic review of published evidence","volume":"141","author":"Maurer","year":"2018","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918302203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918302203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:10:25Z","timestamp":1758791425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674918302203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0091674918302203"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2018.01.031","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic inducible urticaria: A\u00a0systematic review of treatment options","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2018.01.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}